Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TVF Communications

- PMLiVE

Alacrita appoints Stuart Hendry as associate partner

Joins from medical device firm Sphere Medical

Daiichi Sankyo logo

Japan’s Daiichi Sankyo pays $410m for Ambit Biosciences

Gains rights to cancer drug quizartinib

- PMLiVE

EMA wants to embed patient viewpoint within drug assessment

Will pilot CHMP benefit-risk evaluation project

Gilead Sciences

Gilead’s hep C combination Harvoni recommended for EU approval

CHMP backs combination of Sovaldi and ledipasvir

- PMLiVE

Virgo Health names US head

Nancy Caravetta to lead the UK comms agency's new PR practice in New York

- PMLiVE

Sales reps struggle to access doctors

Doctors continue to turn away from face-to-face visits from pharma sales reps and look instead towards mobile technology for information

Sanofi reception

Sanofi provides bursaries to UK patient groups

Older People's Advocacy Alliance receives gold award of £25,000

The benefits of Big Data

Using real-world patient outcomes data

EU flag

EMA backs 15 new medicines for use in EU

Includes new treatments from Gilead, Lilly, Boehringer, AstraZeneca and Janssen

- PMLiVE

Boehringer Ingelheim launches Sound Challenge app

Looks to raise awareness of rare lung disease IPF

Bristol Myers Squibb logo

First phase III data for BMS’ anti-PD1 nivolumab

Opdivo shows promise in melanoma study

Roche's Perjeta pertuzumab

Roche’s Perjeta should be ‘new standard’ in breast cancer

Could improve survival when added to therapy with Herceptin and docetaxel

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links